These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 8056697
1. Efficacy of ciprofloxacin in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis caused by a cloxacillin-tolerant strain and its non-tolerant variant. Voorn GP, Thompson J, Goessens WH, Schmal-Bauer WC, Broeders PH, Michel MF. J Antimicrob Chemother; 1994 Apr; 33(4):785-94. PubMed ID: 8056697 [Abstract] [Full Text] [Related]
2. Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin. Voorn GP, Kuyvenhoven J, Goessens WH, Schmal-Bauer WC, Broeders PH, Thompson J, Michel MF. Antimicrob Agents Chemother; 1994 Mar; 38(3):487-93. PubMed ID: 8203842 [Abstract] [Full Text] [Related]
3. Role of tolerance in cloxacillin prophylaxis of experimental Staphylococcus aureus endocarditis. Voorn GP, Thompson J, Goessens WH, Schmall-Bauer W, Broeders PH, Michel MF. J Infect Dis; 1992 Jul; 166(1):169-73. PubMed ID: 1607692 [Abstract] [Full Text] [Related]
4. Paradoxical dose effect of continuously administered cloxacillin in treatment of tolerant Staphylococcus aureus endocarditis in rats. Voorn GP, Thompson J, Goessens WH, Schmal-Bauer WC, Broeders PH, Michel MF. J Antimicrob Chemother; 1994 Mar; 33(3):585-93. PubMed ID: 8040122 [Abstract] [Full Text] [Related]
9. Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination. Cantoni L, Glauser MP, Bille J. Antimicrob Agents Chemother; 1990 Dec; 34(12):2348-53. PubMed ID: 1965105 [Abstract] [Full Text] [Related]
10. Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis. Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ. Antimicrob Agents Chemother; 1989 Apr; 33(4):519-21. PubMed ID: 2499251 [Abstract] [Full Text] [Related]
12. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats. Cantoni L, Wenger A, Glauser MP, Bille J. J Infect Dis; 1989 May; 159(5):989-93. PubMed ID: 2708846 [No Abstract] [Full Text] [Related]
13. The emergence of resistance to ciprofloxacin during treatment of experimental Staphylococcus aureus endocarditis. Kaatz GW, Barriere SL, Schaberg DR, Fekety R. J Antimicrob Chemother; 1987 Nov; 20(5):753-8. PubMed ID: 3429376 [Abstract] [Full Text] [Related]
14. Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus. Carpenter TC, Hackbarth CJ, Chambers HF, Sande MA. Antimicrob Agents Chemother; 1986 Sep; 30(3):382-4. PubMed ID: 3640590 [Abstract] [Full Text] [Related]
15. Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus. Entenza JM, Vouillamoz J, Glauser MP, Moreillon P. Antimicrob Agents Chemother; 1997 Aug; 41(8):1662-7. PubMed ID: 9257737 [Abstract] [Full Text] [Related]